You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Chemotherapy and other systemic treatment regimens may change due to COVID-19. Find out more at Systemic Treatment Regimens During COVID-19.

What’s New in the Drug Formulary

All new and updated drug and regimen monographs, patient information sheets, as well as safety and advice documents added to the Drug Formulary within the last 30 days are available here.

Regimen
Published Date: 27 May 2022
Cancer Type:
Gynecologic, 
Endometrial, 
Ovary
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Pregnancy/lactation section

Updated
May 2022
Regimen
Published Date: 27 May 2022
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Pregnancy/lactation section

Updated
May 2022
Drug

Published Date: 27 May 2022

Revision Summary:
Drug Monograph: Updated Pregnancy/lactation section
Patient Info Sheet EN: Updated info sheet
Patient Info Sheet FR: Updated info sheet (Fiche d’information mise à jour)
Updated
May 2022
Regimen
Published Date: 25 May 2022
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Revision Summary:

Regimen Monograph: Re-linked NDFP form

Updated
May 2022
Regimen
Published Date: 25 May 2022
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Revision Summary:

Regimen Monograph: Re-linked NDFP form

Updated
May 2022
Regimen
Published Date: 25 May 2022
Cancer Type:
Gastrointestinal, 
Pancreas
Intent: Palliative
Revision Summary:
Regimen Monograph: Changed regimen code from FOLFIRINOX to mFOLFIRINOX; Modified Drug regimen (irinotecan dosing and omit 5FU bolus), Dose modifications and Drug administration sections
Patient Info Sheet EN: Modified Regimen code and What is this treatment section
Updated
May 2022
Regimen
Published Date: 25 May 2022
Cancer Type:
Sarcoma, 
Kaposi's Sarcoma
Intent: Palliative
Revision Summary:

Regimen Monograph: Re-linked NDFP form

Updated
May 2022
Regimen
Published Date: 20 May 2022
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dose modifications, Adverse effects, Interactions, Special precautions, and Monitoring sections

Updated
May 2022
Regimen
Published Date: 20 May 2022
Cancer Type:
Gastrointestinal, 
Pancreas
Intent: Adjuvant
Revision Summary:
Regimen Monograph: Revised Dose modification and Drug administration sections
Patient Info Sheet EN: Modified Regimen code and What is this treatment section
Updated
May 2022
Regimen
Published Date: 20 May 2022
Cancer Type:
Lung, 
Non-Small Cell
Intent: Curative
Revision Summary:

Regimen Monograph: Modified Dose modifications, Adverse effects, Interactions, Special precautions, and Monitoring sections

Updated
May 2022
Drug

Published Date: 20 May 2022

Revision Summary:
Drug Monograph: Updated Indications, Dosing, Adverse effects, Administration guidelines, Warnings/precautions and Monitoring sections
Updated
May 2022
Regimen
Published Date: 20 May 2022
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Drug regimen, Cycle frequency, Dose modifications, Adverse effects, Interactions, Special precautions, and Monitoring sections

Updated
May 2022

Pages